Novavax Inc. (NVAX)
NASDAQ: NVAX
· Real-Time Price · USD
9.58
0.15 (1.59%)
At close: Aug 15, 2025, 3:59 PM
9.63
0.52%
After-hours: Aug 15, 2025, 07:58 PM EDT
Novavax Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.08B | 1.25B | 682.16M | 885.19M | 822.75M | 831.69M | 818.78M | 815.27M | 1.53B | 1.29B | 1.91B | 1.85B | 1.29B | 1.4B | 1.15B | 1.2B | 1.18B | 919.45M |
Cost of Revenue | 125.63M | 147.44M | 182.14M | 294.35M | 332.66M | 352.39M | 337.67M | 370.56M | 706.22M | 921.52M | 902.64M | 724.55M | 289.95M | 18.88M | 3.67M | n/a | n/a | n/a |
Gross Profit | 953.09M | 1.11B | 500.02M | 590.85M | 490.09M | 479.3M | 481.12M | 444.71M | 821.56M | 367.76M | 1.01B | 1.12B | 1B | 1.38B | 1.14B | 1.2B | 1.18B | 919.45M |
Operating Income | 356.08M | 411.41M | -242.83M | -295.32M | -286.93M | -392.47M | -566.51M | -626.82M | -628.38M | -1.17B | -644.74M | -1.23B | -1.41B | -1.27B | -1.69B | -1.04B | -931.26M | -602.45M |
Interest Income | n/a | n/a | n/a | n/a | 2.86M | 5.98M | 10.3M | 14.9M | 16.21M | 13.09M | 8.77M | 4.17M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 431.39M | 488.52M | -176.62M | -279.74M | -288.88M | -395.6M | -543.03M | -550.84M | -585.51M | -1.15B | -653.65M | -1.3B | -1.45B | -1.29B | -1.71B | -1.06B | -943.35M | -612.1M |
Net Income | 422.82M | 478.7M | -187.5M | -284.86M | -294.33M | -398.71M | -545.06M | -548.92M | -586.76M | -1.16B | -657.94M | -1.32B | -1.48B | -1.32B | -1.74B | -1.08B | -949.91M | -615.11M |
Selling & General & Admin | 237.79M | 298.48M | 332.69M | 409.58M | 446.29M | 438.71M | 468.95M | 475.37M | 490.79M | 505.23M | 488.69M | 411.24M | 366.16M | 331.16M | 298.36M | 275.46M | 254.54M | 199.1M |
Research & Development | 358.01M | 387.33M | 391.07M | 451.49M | 470.55M | 583.08M | 737.5M | 830.65M | 1.03B | 1.1B | 1.24B | 1.94B | 2.04B | 2.33B | 2.53B | 1.97B | 1.86B | 1.32B |
Other Expenses | -1.1M | n/a | -8.8M | -14.9M | -17.88M | -17.88M | -96.46M | -159.93M | -156.95M | -156.95M | -67.92M | 1.78M | -2.61M | 50K | -1.6M | -1.74M | 3.61M | 952K |
Operating Expenses | 601.5M | 690.4M | 737.15M | 875.97M | 766.82M | 871.77M | 960.25M | 984.15M | 1.36B | 1.45B | 1.65B | 2.35B | 2.41B | 2.66B | 2.83B | 2.25B | 2.11B | 1.52B |
Interest Expense | 11.62M | 10.24M | 20.07M | 16.61M | 15.23M | 14.21M | 14.42M | 14.9M | 16.21M | 19.32M | 19.52M | 20.06M | 21.07M | 20.81M | 21.13M | 20.94M | 19.86M | 16.94M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -165.37M | -165.37M | -165.37M | -165.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 722.63M | 842.43M | 923.87M | 1.18B | 1.11B | 1.22B | 1.3B | 1.35B | 2.07B | 2.37B | 2.56B | 3.07B | 2.7B | 2.67B | 2.83B | 2.25B | 2.11B | 1.52B |
Income Tax Expense | 8.56M | 9.82M | 10.88M | 5.12M | 5.46M | 3.11M | 2.03M | -1.92M | 1.25M | 2.81M | 4.29M | 23.16M | 26.73M | 28.86M | 29.21M | 12.61M | 6.57M | 3.02M |
Shares Outstanding (Basic) | 162.02M | 161.05M | 160.24M | 160.05M | 148.38M | 139.92M | 123.68M | 103.43M | 89.36M | 86.16M | 79.82M | 78.27M | 78.14M | 79.38M | 75.67M | 74.75M | 74.12M | 73.02M |
Shares Outstanding (Diluted) | 177.22M | 177.63M | 160.24M | 160.05M | 165.85M | 139.92M | 123.68M | 103.43M | 104.06M | 86.16M | 79.82M | 78.27M | 78.14M | 80.71M | 75.67M | 74.75M | 74.12M | 73.03M |
EPS (Basic) | 2.61 | 3.06 | -1.21 | -2.14 | -2.64 | -3.1 | -5.46 | -6.3 | -7.19 | -14.37 | -8.4 | -17.3 | -19.46 | -17.68 | -23.29 | -14.81 | -13.71 | -9.26 |
EPS (Diluted) | 2.26 | 2.65 | -1.33 | -2.26 | -2.76 | -3.17 | -5.53 | -6.37 | -7.26 | -14.37 | -8.44 | -17.34 | -19.5 | -17.72 | -23.29 | -14.81 | -13.71 | -9.26 |
EBITDA | 495.57M | 554.89M | -108.04M | -216.35M | -228.25M | -337.06M | -487.39M | -497.69M | -534.02M | -1.1B | -604.11M | -1.25B | -1.41B | -1.25B | -1.68B | -1.03B | -916.49M | -589.24M |
EBIT | 454.45M | 510.21M | -156.54M | -263.13M | -273.65M | -381.39M | -528.62M | -535.94M | -569.3M | -1.13B | -633.77M | -1.28B | -1.43B | -1.27B | -1.69B | -1.04B | -923.49M | -595.16M |
Depreciation & Amortization | 41.12M | 44.69M | 48.5M | 46.77M | 45.39M | 44.33M | 41.23M | 38.25M | 35.28M | 31.93M | 29.65M | 25.5M | 21.42M | 17.11M | 12.66M | 10.78M | 7.71M | 6.28M |